Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "Yes, the licensing can continue."

Does this mean that we should expect absolutely no license activity before the case is over?Which means, even if the USPTO came out with a positive decision on Monday, we should still expect no license activity?Is this non activity also a breach of the commercialization agreement?Could that mean yet another suit against TPL

http://agoracom.com/ir/patriot/forums/discussion/topics/424312-suit-against-tpl/messages/1391979

.

.

.

Be well

Share
New Message
Please login to post a reply